| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Chemicals
|
Compare with Industry peers |
| Website | http://www.chemcrux.com | |
| Market Cap | 431.68 Cr. | |
| Enterprise Value(EV) | 431.68 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 10.07 | Trailing Twelve Months Ending 2022-03 |
| Price-Earning Ratio (PE) | 28.98 | Trailing Twelve Months Ending 2022-03 |
| Industry PE | 26.16 | Trailing Twelve Months Ending 2022-03 |
| Book Value / Share | 36.95 | Trailing Twelve Months Ending 2022-03 |
| Price to Book Value | 7.90 | Calculated using Price: 292.00 |
| Dividend Yield | 0.69 | Period Ending 2022-03 |
| No. of Shares Subscribed | 1.48 Cr. | 14,808,840 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| The Company is an ISO 9001:2008 and ISO 14001:2004 certified company, engaged in high pressure Oxidation, Chlorosulfonation, Nitration and Aceylation forb manufacturing of intermediates for bulk drugs, dyes and pigments. The Company exports its products to Europe, Egypt and United States of America. It also caters to customers with tailor made products. The Company have product portfolio of intermediates for bulk drugs, API, dyes and pigments industries. Their major selling products are Lassamide, various Chloro Benzoic Acids, and Nitro Benzoic Acids. | ||
| 1 Day |
|
+1.92% |
| 1 Week |
|
-2.13% |
| 1 Month |
|
-3.98% |
| 3 Month |
|
-21.47% |
| 6 Month |
|
-32.75% |
| 1 Year |
|
+92.93% |
| 2 Year |
|
+499.96% |
| 5 Year |
|
+2514.15% |
| 10 Year |
|
| 1 years | 2022-03 | |
| Return on Equity (%) | 27.26 | |
| Return on Capital Employed (%) | 31.70 | |
| Return on Assets (%) | 18.03 |
| Particulars | 1 years | 2022-03 Rs. Cr. |
| Shh. Funds | 55 | |
| Non Curr. Liab. | 2 | |
| Curr. Liab. | 26 | |
| Minority Int. | ||
| Equity & Liab. | 83 | |
| Non Curr. Assets | 28 | |
| Curr. Assets | 55 | |
| Misc. Exp. not W/O | 0 | |
| Total Assets | 83 |
| Particulars | 1 years | 2022-03 Rs. Cr. |
| Net Sales | 95 | |
| Other Income | 1 | |
| Total Income | 96 | |
| Total Expenditure | -75 | |
| PBIDT | 22 | |
| Interest | 0 | |
| Depreciation | -1 | |
| Taxation | -5 | |
| Exceptional Items | ||
| PAT | 15 | |
| Minority Interest | ||
| Share Associate | ||
| Other Related Items | ||
| Consolidated Net Profit | 15 | |
| Adjusted EPS | 10 |
| Particulars | 1 years | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 6 | |
| Cash Fr. Inv. | -4 | |
| Cash Fr. Finan. | 7 | |
| Net Change | 9 | |
| Cash & Cash Eqvt | 12 |
|
Thu, 16 Feb 2023
General Update And Information The Company has declared the unaudited financial results for the quarter and nine months ended 31st December 2022 on 13th February 2023. Further to provide the shareholders with the deeper insights the Company is submitting information and/or updates. |
|
Wed, 15 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Publication of Standalone Unaudited Financial Results for the quarter and nine months ended 31st December 2022 |
|
Mon, 13 Feb 2023
Unaudited Standalone Financial Results For The Third Quarter And Nine Months Ended 31St December 2022 Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015 we enclose the Unaudited Standalone Financial Results for the quarter and nine months ended 31st December 2022. |
| Wed, 29 Mar 2023 |
High Decrease in 3 Months
|
High Decrease in 6 Months
|
High Increase in 1 Year
|
High Increase in 2 Years
|
High Increase in 5 Years
|
Equities
M.F.
Sectors